Okyo Pharma Limited

Okyo Pharma (OKYO)

Buy
Sell
Company name:Okyo Pharma Limited
EPIC:OKYOTrading Currency:GBX
Market Sector:SQS3ISIN:GG00BD3FV870
Market Segment:SSQ3Share Type:DE
WWW Address:www.okyopharma.comDescription:ORD NPV
Industry Sector:MINING
 Price Price Change [%] Bid Offer Open High Low Volume
 12.00 images.advfn.com/imagesnew/2/gb/up 0.5 [4.35] 11.00 12.00 11.00 11.75 11.00 284,099
 Market Cap. [m] Shares In Issue [m] Beta EPS DPS PE Ratio Yield 52-Wks-Range
 76.36 636.30 -0.00 -0.01 - - - 18.75 - 0.75

Okyo Pharma Key Figures

(at previous day's close)
Market Cap.76.36m
Shares In Issue636.30m
Prev. Close11.50
PE Ratio- 
Dividend Yield-%
EPS - basic-0.01p
Dividend PS-p
Dividend Cover- 
Cash Flow PS-0.24p
Return On Equity (ROE)-1,471.60%
Operating Margin-%
PEG Factor- 
EPS Growth Rate92.86%
Dividends PS Growth Rate-%
Net Debt-0.15m
Gross Gearing56.16%
Quick Assets0.58m
Net Working Capital0.25m
Intangibles / Fixed Assets-%
Turnover PS-p
Pre-Tax Profit PS-0.59p
Retained Profit PS-0.59p
Cash PS0.08p
Net Cash PS0.02p
Net Tangible Asset Value PS *0.04p
Net Asset Value PS0.04p
Spread1.00 (8.33%) 

Okyo Pharma Balance Sheet

LSE:OKYO:Liabilities+EQLSE:OKYO:Assets

Share Price Performance

Sample Period HighLow
1 week13.0010.45
4 weeks13.007.50
12 weeks18.757.50
1 year18.750.75

Share Price Chart (5 years)

Okyo Pharma Historic Returns

Period OpenChange%Open Avg.Avg. Daily Vol [m]Total Vol [m]VWAP
1 week11.250.756.6710.450.6511.65
4 weeks9.252.7529.737.500.8610.69
12 weeks10.251.7517.077.501.3613.85
26 weeks3.108.90287.101.001.0311.24
1 year3.758.25220.000.750.6810.60
3 years2.509.50380.000.750.496.87
5 years3.009.00300.000.750.415.83

Okyo Pharma Key Management Ratios

Okyo Pharma Investment Ratios

(Market value analysis) at previous day's close
PQ Ratio- 
PE Ratio- 
Tobin's Q Ratio 58.95 
Tobin's Q Ratio (excl. intangibles)58.95 
Dividend Yield-%
Market-to-Book Ratio298.95 
Price-to-Pre-Tax Profit PS-20.31 
Price-to-Retained Profit PS-20.31 
Price-to-Cash Flow PS-50.01 
Price-to-Sales PS- 
Price-to-Net Tangible Asset Value PS298.95 
Price-to-Cash PS158.69 
Net Working Capital PS0.04 
Price Pct to Working Capital PS299.94%
Earnings Yield-%
Average PE13.33 
Years in average1 
PE to PE average-%

Okyo Pharma Financial Ratios

(Leverage Ratios)
Debt Ratio-%
Debt-to-Equity Ratio- 
Debt-to-Equity Ratio (excl. Intgbl)- 
Debt-to-Equity Market Value- 
Net Gearing-26.43%
Net Gearing (excl. Intangibles)-26.43%
Gross Gearing56.16%
Gross Gearing (excl. Intangibles)56.16%
Gearing Under 1 Year56.16%
Gearing Under 1 Year (excl. Intgbl)56.16%
Assets/Equity2.28 
Cash/Equity188.38 
(Liquidity Ratios)
Net Working Capital to Total Assets43.70%
Current Ratio1.78 
Quick Ratio (Acid Test)1.78 
Liquidity Ratio1.47 
Cash & Equiv/Current Assets82.71%
(Solvency Ratios)
Enterprise Value75.87m
CFO/Sales- 
CFO/Attributable Profit- 
CFO/Assets-2.62 
CFO/Debt-4.67 
Total Debt/Equity Market Value0.00 
Total Debt/Sales- 
Total Debt/Pre-Tax Profit-0.09 
Total Debt0.33m
Total Debt/Net Current Assets1.29%
(Dodds - Graham Ratios)
3 yr Compound Earnings Growth-58.51%
5 yr Compound Earnings Growth-63.19%
10 yr Compound Earnings Growth-%
Earn drops > 5% in 10yrs4 
Beta (60-Mnth)Beta (36-Mnth)
-0.0022-0.0047

Okyo Pharma Operating Ratios

(Profitability Ratios)
Return On Capital Employed (ROCE)-1,471.60%
Return On Assets (ROA)-290.20%
Net Profit Margin-%
Assets Turnover- 
Return On Equity (ROE)-1,471.60%
Return On Investment (ROI)-346.07%
Dividend Payout Ratio-%
Plowback Ratio100.00%
Growth from Plowback Ratio-%
Net Income Of Revenues-%
(Asset Utilisation Multiples)
Shareholders Equity Turnover- 
Fixed Assets Turnover- 
Current Assets Turnover- 
Net Working Capital Turnover 
Inventory Turnover- 
(Other Operating Ratios)
Total Assets-to-Sales- 
Debtors-to-Sales-%
Debt Collection Period-Days

Okyo Pharma Dividends

Announcement DateTypeCurr.Dividend AmountPeriod StartPeriod EndEx DateRecord DatePayment DateTotal Dividend Amount
16 Apr 2010SpecialGBX1.8531/03/200931/03/201028/04/201030/04/201018/05/20101.85

Okyo Pharma Fundamentals

 31 Mar 2016 (GBP)31 Mar 2017 (GBP)31 Mar 2018 (GBP)31 Mar 2019 (GBP)
turnover--------m
pre tax profit-0.70--0.54--53.15--3.76-m
attributable profit-0.70--0.54--53.15--3.76-m
retained profit-0.70--0.54--53.15--3.76-m
eps - basic (p)0.15 -0.14 -0.14 -0.01 
eps - diluted (p)0.15 -0.14 -0.14 -0.01 
dividends per share- - - - 

Okyo Pharma Balance Sheet

 31 Mar 2016 (GBP)31 Mar 2017 (GBP)31 Mar 2018 (GBP)31 Mar 2019 (GBP)
LSE:OKYO:Liabilities+EQLSE:OKYO:AssetsLSE:OKYO:Liabilities+EQLSE:OKYO:AssetsLSE:OKYO:Liabilities+EQLSE:OKYO:AssetsLSE:OKYO:Liabilities+EQLSE:OKYO:Assets
 31 Mar 2016 (GBP)31 Mar 2017 (GBP)31 Mar 2018 (GBP)31 Mar 2019 (GBP)
ASSETS
fixed assets fixed assets0.120.52%0.060.27%--%0.00-m
intangibles intangibles18.5482.79%18.9084.95%--%--m
fixed investments fixed investments--%--%--%--m
current assets - other current assets - other--%--%--%--m
stocks stocks--%--%--%--m
debtors debtors0.170.75%0.140.64%0.000.00%0.10-m
cash & securities cash & securities3.5715.94%3.1514.14%2.01100.00%0.48-m
TOTAL22.40100%22.25100%2.01100%0.58100%m
LIABILITIES
creditors - short creditors - short0.130.56%0.210.93%0.094.54%0.33-m
creditors - long creditors - long--%--%--%--m
creditors - other creditors - other--%--%--%--m
subordinated loans subordinated loans--%--%--%--m
insurance funds insurance funds--%--%--%--m
TOTAL0.130.56%0.210.93%0.094.54%0.33-m
EQUITY
ord cap, reserves ord cap, reserves22.2799.44%22.0499.07%1.9295.46%0.26-m
prefs, minorities prefs, minorities--%--%--%--m
TOTAL22.2799.44%22.0499.07%1.9295.46%0.26-m
OTHER
NAV Basic- - - - 
NAV Diluted- - - - 

Okyo Pharma Cash Flow Statement

31 Mar 2016 (GBP)31 Mar 2017 (GBP)31 Mar 2018 (GBP)31 Mar 2019 (GBP)
Operating CF-0.45-0.45-1.00-1.53m
Pre-Financing CF-0.69-0.75-1.00-1.53m
Retained CF-0.80-0.42-1.00-1.53m

Okyo Pharma Brokers

Broker infomation is not available for this class of stock.
ADVFN Advertorial
Your Recent History
LSE
OKYO
Okyo Pharm..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:gb D:20201021 04:20:56